James Sigler

Jim has been developing drugs for over 30 years, building CMC roadmaps that integrate with Clinical, Financial, Quality, and Regulatory to ensure that strategy, team development, systems build-out, and subsequent execution all march together. Jim is developing strategy and building infrastructure aligned with Concerto’s goal of initiating first-in-human studies. Jim has been working in the microbiome space for over six years, leading manufacturing for four different programs and successfully completing a pivotal study.